Neoadjuvant cisplatin plus ifosfamide in patients with stage IIB cervical cancer: A single center phase II study

International Journal of Gynecological Cancer

Volumn 7, Issue 2, 1997, Pages 158-162

  De Jonge, E T M ^a,b   Falkson, G ^a   Burger, W ^a   Schoeman, L ^a   Lindeque, B G ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b Dept of Obstetrics and Gynecology   (South Africa)

Author keywords

cervical cancer; neoadjuvant chemotherapy

Indexed keywords

CISPLATIN; IFOSFAMIDE; MESNA;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

EID: 0030977303     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1997.00438.x     Document Type: Article

References (29)

1. Sitas F, Terblanche M, Madhoo J. Incidence and geographical distribution of historically diagnosed cancer in South Africa, 1990 and 1991. National Cancer Registry of South Africa. Annual Statistical Report. Johannesburg: South African Institute for Medical Research, 1996.
2. Grant MC. Carcinoma of the cervix - a tragic disease in South Africa. S Afr Med J 1982; 61: 819-22.
3. Vermorken JB. The role of chemotherapy in squamous cell carcinoma of the uterine cervix: A review. Int J Gynecol Cancer 1993; 3: 129-42.
4. Vermorken JB. Neoadjuvant chemotherapy (NACT) in cervical cancer: Still promising? Ann Oncol 1992; 3: 97-101.
5. Anonymous. Changes to the 1985 FIGO report on the result of treatment in gynecological cancer. Int J Gynecol Obstet 1987; 25: 87-8.
6. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (CCT) 1982; 5: 649-55.
7. Sutton GP, Blessing JA, Manetta, et al. Gynecologic Oncology Group studies with ifosfamide. Semin oncol 1992; 19: 31-4.
8. Thigpen T, Lambuth BW, Vance RB. Ifosfamide in the management of gynecologic cancers. Semin Oncol 1990; 17 (Suppl. 4): 11-18.
9. Goldin A. Ifosfamide in experimental tumour systems. Semin Oncol 1982; 9 (Suppl. 1): 14-23.
10. Sardi J, Sananes C, Giaroli A, et al. Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 1990; 38: 486-93.
11. Kumar L, Kaushal R, Nandy M, et al. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: A randomized study. Gynecol Oncol 1994; 54: 307-15.
12. Van Dyk JJ, Falkson G, Falkson HC, et al. Bleomycin-A clinical evaluation of the agent on its own or in combination with mitomycin-C. S Afr Med J 1972; 46: 1921-6.
13. Highley MS, Samandas N, Ziras N, et al. A phase II study of ifosfamide and bleomycin in advanced or recurrent cervical carcinoma. Int J Gynecol Cancer 1996; 6: 323-7.
14. Kim DS, Moon H, Hwang YY, et al. Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa, and IIb with bulky tumor. Gynecol Oncol 1988; 29: 321-32.
15. Kirsten F, Atkinson KH, Coppleson JVM, et al. Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer. Br J Obstet Gynaecol 1987; 94: 583-8.
16. Symonds RP, Burnett RA, Habeshew T, et al. The prognostic value of chemotherapy given before radiotherapy in advanced cancer of the cervix. Br J Cancer 1989; 59: 473-5.
17. Souhami L, Gil RA, Allan SE, et al. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. J Clin Oncol 1991; 9: 970-7.
18. Tattersall MHN, Lorvidhaya V, Vootiprux V, et al. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. J Clin Oncol 1995; 13: 444-51.
19. Im DS, Moon H, Kim KT, et al. Two-year survival: Preoperative adjuvant chemotherapy in the treatment of cervical cancer Stages Ib and II with bulky tumor. Gynecol Oncol 1989; 33: 225-30.
20. Panici PB, Scambia G, Baiocchi G, et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival. Cancer 1991; 67: 372-9.
21. Bolis G, Frigerio L, Melpignano M, et al. Primary chemotherapy including platinum for bulky and advanced cervical cancer. Ann Oncol 1992; 3 (Suppl. 5): 106.
22. Erazo A, Cervantez G, Ortega B, et al. A phase II trial of ifosfamide, mesna and cisplatin chemotherapy as neoadjuvant or palliative treatment for cervical cancer. Proc Am Soc Clin Oncol 1993; 12: 266.
23. Rabinovich M, Vallejo C, Perez J, et al. Neoadjuvant chemotherapy with ifosfamide and cisplatin in advanced cervical carcinoma. Proc Am Soc Clin Oncol 1993; 12: 262.
24. Moisa C, Díaz E, Barés J, et al. Neoadjuvant ifosfamide (IFX) plus cisplatin (CDP) for locally advanced carcinoma of the cervix. Proc Am Soc Clin Oncol 1996; 15: 278.
25. Kuehnle H, Meerpohl HG, Eiermann W, et al. Neoadjuvant therapy for cervical cancer. Semin Oncol 1992; 19 (Suppl. 2): 94-8.
26. Maranz A, Litovska S, Etcheverry G, et al. Neoadjuvant chemotherapy (NCT), surgery and concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix: Clinical and histopathological evaluation. Proc Am Soc Clin Oncol 1991; 10: 189.
27. Tobias J, Buxton EJ, Blackledge G, et al. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer. Cancer Chemother Pharmacol 1990; 26 (Suppl. 1): S59-S62.
28. Gamucci T, Zueli M, Calabresi F, et al. Preoperative chemotherapy for cervicocarcinoma: Clinical and biological evaluation. Proc Am Soc Clin Oncol 1995; 14: 268.
29. Panici PB, Greggi S, Scambia G, et al. High-dose cisplatin and bleomycin neoadjuvant chemotherapy plus radical surgery in locally advanced cervical carcinoma: A preliminary report. Gynecol Oncol 1991; 41: 212-16.